Algo version: 0.98b
Hexima Limited is listed at the ASX Exchange
Hexima Limited [HXL.AX]
ASX Sector: Healthcare Industry:Biotechnology

Is Hexima Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Hexima Limited 10 years ago, but if you had invested on Monday 30th of November 2020 when the price was $0.195, you would have made a loss of $-0.182 per share or -93.33%

No, the average daily trading liquidity for Hexima Limited is $160 895 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Hexima Limited has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Hexima Limited to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.28 and is down -0.0099999999999998 over the last 30 days.